Immunologic mechanisms of antitumor activity
- 1 June 2002
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (3) , 5-11
- https://doi.org/10.1053/sonc.2002.33076
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- B7 costimulatory molecules from malignant cells in patients with B-cell chronic lymphoproliferative disorders trigger T-cell proliferationCancer, 2000
- Taking lessons from dendritic cells: multiple xenogeneic ligands for leukocyte integrins have the potential to stimulate anti-tumor immunityGene Therapy, 1999
- Variable expression of CD3‐ζ chain in tumor‐infiltrating lymphocytes (TIL) derived from renal‐cell carcinoma: Relationship with til phenotype and functionInternational Journal of Cancer, 1995
- Tumor Antigen-Specific Immunization of Bone Marrow Transplantation Donors as Adoptive Therapy Against Established TumorJNCI Journal of the National Cancer Institute, 1995
- T‐helper‐ and accessory‐cell‐independent cytotoxic responses to human tumor cells transfected with A B7 retroviral vectorInternational Journal of Cancer, 1994
- Signals and signs for lymphocyte responsesCell, 1994
- Monocytes and macrophages in cancer immunotherapyResearch in Immunology, 1993
- Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cellsImmunology Today, 1993
- The origin and function of tumor-associated macrophagesImmunology Today, 1992
- Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.The Journal of Experimental Medicine, 1988